HBV/HDV-IN-2
HBV/HDV-IN-2 (Compd 143) is a HBV, HDV and PD-1/PD-L1 inhibitor, with an EC50 of 35 nM for T cell activation[1].
Product Specifications
CAS Number
[3034161-76-4]
UNSPSC
12352005
Target
HBV; PD-1/PD-L1
Type
Reference compound
Related Pathways
Anti-infection; Immunology/Inflammation
Applications
COVID-19-anti-virus
Field of Research
Cancer; Infection; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/hbv-hdv-in-2.html
Smiles
CC1=C(C=CC=C1NC(C2=CC(OC)=C(CN3CC[C@@H](O)C3)C=N2)=O)C4=NC=CC(C5=CC=C(CNC6CCN(C(C)=O)CC6)C(OC)=N5)=C4Cl
Molecular Formula
C38H44ClN7O5
Molecular Weight
714.25
References & Citations
[1]Andrew G. Cole, et al. Substituted 1-arylaminocarbonyl-1'-heteroaryl compounds, substituted 1-heteroarylaminocarbonyl-1'-heteroaryl compounds and methods using same. Patent. WO2024069448A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
037722-HRP 200 µL
LDB2, CT (LDB2, CLIM1, LIM domain-binding protein 2, Carboxyl-terminal LIM domain-binding protein 1, LIM domain-binding factor CLIM1) (Azide free) (HRP) discontinued
Ask
View Details